Torrent Pharma Extends Shelcal® legacy into the Adult Nutrition Powder Segment with the launch of Shelcal® Total

Mumbai, 23rd July 2025: Torrent Pharmaceuticals Ltd. (NSE: TORNTPHARM / BSE: 500420) has announced the launch of Shelcal® Total, a scientifically formulated adult nutrition supplement powder that expands its flagship Shelcal® brand into the rapidly growing Nutrition segment.

Shelcal®—with a three-decade legacy of trust—has remained India’s #1 calcium supplement brand since its acquisition by Torrent Pharma in 2013. The portfolio has since expanded with consumer-friendly innovations like Shelcal® Pro Gummies and Shelcal® Pro Kids Gummies, reinforcing the brand’s relevance across age groups and evolving health needs. Shelcal® Total now marks the brand’s evolution into a modern, consumer-focused nutrition portfolio.

“India is facing a growing nutrition gap driven by lifestyle changes, poor dietary habits, and rising stress levels — all of which contribute to deficiencies across age groups,” said Amal Kelshikar Chief Commercial Officer, India Business, Torrent Pharma. “As health awareness increases and more adults are in need of convenient holistic nutrition, the demand for trusted, convenient solutions is only accelerating. Shelcal® Total is our answer to that need — a science-backed, great-tasting supplement that makes comprehensive daily nutrition more accessible and easier to adopt, while upholding Shelcal’s long-standing credibility and consumer trust.”

Shelcal® Total is a comprehensive daily supplement combining high-quality protein, essential vitamins, minerals, and functional nutrients to support bone, muscle and joint health, energy, immunity, gut health, brain health and skin health —addressing the everyday nutritional gaps faced by modern Indian adults. Formulated with vegetarian-origin ingredients, Shelcal® Total contains no added sugar, artificial colours and flavours, making it suitable for health-conscious adults managing their calorie intake. Each serving delivers targeted nutrients including calcium, magnesium, vitamin D3 and K2 for bone strength, most notably, it has glucosamine and bamboo shoot extract for joint health, —another often overlooked area in mainstream nutrition. 

“Through the years, I have observed that the challenge most Indian adults, particularly those over 30, face aren’t just individual nutrient gaps, but how these interconnected deficiencies affect bone density, muscle mass, and joint mobility." said Nmami Agarwal, Certified Nutritionist. "Shelcal® Total has comprehensive approach with nutrients to addresses the common prevalent deficiencies, even beyond bone and joint health. For busy professionals and aging adults who struggle to meet their nutritional needs through diet alone, this is a practical, science-backed solution due to its multitude of nutrients to help fulfil required RDA." said Nmami Agarwal. 

The launch comes at a pivotal time for India’s nutrition supplements market, which stood at USD 42.97 billion in 2024 and is projected to grow at a CAGR of 8.1% through 2030. Powdered supplements account for nearly 38% of the market, preferred for their bioavailability and ease of daily integration—positioning Shelcal® Total strongly in this high-growth category.

Shelcal® Total is now available in 200 gm & 400 gm packs in Vanilla and Dark Chocolate flavours across key retail pharmacies, modern trade, and e-commerce platforms, including Amazon, 1mg, Flipkart, and PharmEasy.

To know more, visit https://shelcal.com/shelcal-total

ABOUT TORRENT PHARMACEUTICALS LTD:

Torrent Pharma, with annual revenues of more than Rs 11,500 crores, is the flagship Company of the Torrent Group, with group revenues of ~Rs 45,000 crores. It is ranked 7th in the Indian Pharmaceuticals Market and is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Gastro Intestinal (GI), Central Nervous System (CNS) and Cosmo-Dermatology.

It is a specialty-focused company with ~76% of its revenues in India from chronic & sub- chronic therapies. It has presence in 50+ countries and is ranked No. 1 amongst the Indian pharma Companies in Brazil and Germany. Torrent has 8 manufacturing facilities, of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing approximately 750+, scientists.